Tirzepatide Prescribing at BEWICK CRESCENT SURGERY
Drugs used in diabetes | Endocrine System
Items (12m)
660
Total Quantity
677
NHS Cost
£64.3K
vs National Avg
+239.8%
BEWICK CRESCENT SURGERY prescribed 660 items of Tirzepatide over the last 12 months at a cost of £64,276 to the NHS. This is 239.8% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
4
Jun 2026
5
Jun 2026
15
Jun 2026
20
Jun 2026
36
Jun 2026
47
Jun 2026
59
Jun 2026
68
Jun 2026
83
Jun 2026
89
Jun 2026
103
Jun 2026
131
Prescribing Details
| Total Items | 660 |
|---|---|
| Total Quantity | 677 |
| Total NHS Cost | £64,276 |
| Presentations | 5 different forms |
| vs National Average | +239.8% |
Tirzepatide Prescribing Comparison
| This practice | 660 items |
|---|---|
| National average per practice | 194 items |
| Difference | +239.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.